BrainIAC, a new foundation model from Mass General Brigham, outperforms traditional AI approaches in analyzing brain MRI for tasks like brain age estimation and cancer prognosis.
Key Details
- 1BrainIAC was pretrained on nearly 49,000 brain MRI scans using self-supervised learning.
- 2Validated across seven diverse clinical MRI tasks, including brain age, dementia risk, tumor mutation detection, and survival prediction.
- 3Outperformed three conventional, task-specific AI models, especially in scenarios with limited labeled data.
- 4Demonstrated strong generalizability across healthy and diseased cases as well as different MRI types.
- 5Study published in Nature Neuroscience, developed by Mass General Brigham, and funded by NIH/NCI among others.
Why It Matters
This work introduces a flexible, generalizable AI tool that could streamline the adoption of imaging AI in clinical practice, particularly where annotated data is limited. BrainIAC's ability to perform well across a range of complex imaging tasks may help accelerate personalized medicine and clinical decision making in neuroradiology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.